| Literature DB >> 2825364 |
R A Spence1, A Rosen, J E Krige, R L Blumgart, C R Temple-Camp, J Terblanche.
Abstract
Hepatocellular carcinoma is often an aggressive tumour and, if unresectable, carries a poor prognosis, especially in the presence of jaundice. We report on a jaundiced patient with an unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin (Adriamycin). The initial response of the patient has been encouraging. This form of therapy deserves further evaluation in patients with unresectable hepatocellular carcinoma.Entities:
Mesh：
Substances：
Year: 1987 PMID： 2825364
Source DB: PubMed Journal: S Afr Med J